Younossi Y - Search Results

1

Nonalcoholic fatty liver disease in lean individuals in the United States.

Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B, Srishord M. Younossi ZM, et al. Among authors: younossi y. Medicine (Baltimore). 2012 Nov;91(6):319-327. doi: 10.1097/MD.0b013e3182779d49. Medicine (Baltimore). 2012. PMID: 23117851 Free article.

2

Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS).

Hossain N, Stepanova M, Afendy A, Nader F, Younossi Y, Rafiq N, Goodman Z, Younossi ZM. Hossain N, et al. Among authors: younossi zm, younossi y. Scand J Gastroenterol. 2011 Apr;46(4):479-84. doi: 10.3109/00365521.2010.539251. Epub 2010 Nov 30. Scand J Gastroenterol. 2011. PMID: 21114431

3

Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M. Younossi ZM, et al. Among authors: younossi y. Clin Gastroenterol Hepatol. 2011 Jun;9(6):524-530.e1; quiz e60. doi: 10.1016/j.cgh.2011.03.020. Epub 2011 Mar 25. Clin Gastroenterol Hepatol. 2011. PMID: 21440669

4

Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity.

Stepanova M, Lam B, Younossi Y, Srishord MK, Younossi ZM. Stepanova M, et al. Among authors: younossi zm, younossi y. J Viral Hepat. 2012 May;19(5):341-5. doi: 10.1111/j.1365-2893.2011.01554.x. Epub 2011 Nov 9. J Viral Hepat. 2012. PMID: 22497813

5

Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens.

Younossi ZM, Stepanova M, Henry L, Nader F, Younossi Y, Hunt S. Younossi ZM, et al. Among authors: younossi y. Medicine (Baltimore). 2016 Jul;95(28):e4151. doi: 10.1097/MD.0000000000004151. Medicine (Baltimore). 2016. PMID: 27428205 Free PMC article.

6

The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.

Younossi ZM, Blissett D, Blissett R, Henry L, Stepanova M, Younossi Y, Racila A, Hunt S, Beckerman R. Younossi ZM, et al. Among authors: younossi y. Hepatology. 2016 Nov;64(5):1577-1586. doi: 10.1002/hep.28785. Epub 2016 Sep 26. Hepatology. 2016. PMID: 27543837

7

In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered.

Younossi Z, Blissett D, Blissett R, Henry L, Younossi Y, Beckerman R, Hunt S. Younossi Z, et al. Among authors: younossi y. Liver Int. 2018 Feb;38(2):258-265. doi: 10.1111/liv.13519. Epub 2017 Aug 24. Liver Int. 2018. PMID: 28719013

8

Epidemiology of chronic liver diseases in the USA in the past three decades.

Younossi ZM, Stepanova M, Younossi Y, Golabi P, Mishra A, Rafiq N, Henry L. Younossi ZM, et al. Among authors: younossi y. Gut. 2020 Mar;69(3):564-568. doi: 10.1136/gutjnl-2019-318813. Epub 2019 Jul 31. Gut. 2020. PMID: 31366455

9

Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.

Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM. Paik JM, et al. Among authors: younossi zm, younossi y. Hepatology. 2020 Nov;72(5):1605-1616. doi: 10.1002/hep.31173. Epub 2020 Oct 27. Hepatology. 2020. PMID: 32043613

10

Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities.

Golabi P, Paik JM, Arshad T, Younossi Y, Mishra A, Younossi ZM. Golabi P, et al. Among authors: younossi zm, younossi y. Hepatol Commun. 2020 May 19;4(8):1136-1148. doi: 10.1002/hep4.1534. eCollection 2020 Aug. Hepatol Commun. 2020. PMID: 32766474 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters